Prestige Consumer Healthcare Inc.·Healthcare

Premium Brands has dropped into my $80–$90 buy range, presenting a compelling entry after a sharp pullback. PBH's M&A pipeline has slowed, but the Stampede acquisition adds significant U.S. capacity and growth potential, despite some near-term margin dilution. Management is shifting toward equity-funded acquisitions to protect leverage, likely resulting in higher share count but maintaining balance sheet flexibility.

Boring, cash-generating businesses like regional grocers often shine when uncertainty rises in the market. These three tickers are the kinds of steady names you build into slowly as volatility creates opportunities.

Jin Medical International (NASDAQ: ZJYL - Get Free Report) and Prestige Consumer Healthcare (NYSE: PBH - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk and earnings. Volatility and Risk Jin Medical International

Prestige Consumer Healthcare Inc. (NYSE: PBH - Get Free Report) has been assigned an average recommendation of "Hold" from the seven research firms that are covering the firm, Marketbeat reports. Four analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1 year target price

Premium Brands (TSE: PBH) executives said the company finished fiscal 2025 with strong sales growth and improving fourth-quarter profitability despite what management described as significant commodity inflation headwinds, particularly record-high beef costs for most of the year and higher chicken costs in the first half. On the company's year-end conference call, CEO George Paleologou and CFO

Premium Brands Holdings Corporation (PBH:CA) Q4 2025 Earnings Call Transcript
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Healthcare
Medical - Distribution
600
2005-02-10
0.47